Skip to main navigation Skip to search Skip to main content

AN INTERVENTIONAL PHASE 1b/2, OPEN-LABEL STUDY TO INVESTIGATE THE TOLERABILITY, ANTITUMOR ACTIVITY, AND PHARMACOKINETICS OF PF-08634404 MONOTHERAPY OR IN COMBINATION WITH ENFORTUMAB VEDOTIN IN ADULT PARTICIPANTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER

Project: Research

Project Details

StatusActive
Effective start/end date14/05/26 → 13/05/31

Clinical Trial Phase

  • Phase I
  • Phase II
  • External Sponsor